Aura Biosciences Inc. (AURA)

AI Score

Unlock

5.40

-0.17 (-3.05%)

At close: Apr 16, 2025, 3:59 PM

5.39

-0.19%

After-hours: Apr 16, 2025, 07:56 PM EDT

Aura Biosciences Balance Sheet Statement

Financials in USD. Fiscal year is January - December.

Fiscal Year	Q4 2024	Q3 2024	Q2 2024	Q1 2024	Q4 2023	Q3 2023	Q2 2023	Q1 2023	Q4 2022	Q3 2022	Q2 2022	Q1 2022	Q4 2021	Q3 2021	Q2 2021	Q1 2021	Q4 2020
Period Ending	Dec 31, 2024	Sep 30, 2024	Jun 30, 2024	Mar 31, 2024	Dec 31, 2023	Sep 30, 2023	Jun 30, 2023	Mar 31, 2023	Dec 31, 2022	Sep 30, 2022	Jun 30, 2022	Mar 31, 2022	Dec 31, 2021	Sep 30, 2021	Jun 30, 2021	Mar 31, 2021	Dec 31, 2020
Cash & Equivalents	31.69M	25.41M	30.07M	26.28M	41.08M	55.58M	47.73M	38.49M	121.58M	61.11M	53.85M	108.38M	149.06M	81.83M	92.2M	99.69M	17.39M
Short-Term Investments	119.4M	148.97M	157.34M	176.59M	185.09M	93.47M	114.28M	135.03M	67.23M	50.41M	68.28M	24.9M	n/a	n/a	n/a	n/a	n/a
Long-Term Investments	n/a	n/a	768K	768K	768K	768K	768K	768K	768K	768K	893K	125K	125K	125K	125K	75K	n/a
Other Long-Term Assets	1.29M	790K	443K	453K	509K	685K	700K	623K	423K	n/a	n/a	n/a	n/a	1.58M	335K	n/a	75K
Receivables	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a
Inventory	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a
Other Current Assets	1.83M	9.1M	7.48M	8.12M	3.83M	4.51M	3.33M	4.08M	5.72M	3.97M	4.46M	4.38M	1.91M	1.55M	639K	981K	1.01M
Total Current Assets	160.62M	183.48M	195.6M	212.25M	231.79M	153.89M	166.21M	179.12M	196.7M	115.91M	127.67M	139.58M	153.7M	83.46M	92.88M	100.72M	18.45M
Property-Plant & Equipment	20.59M	21.07M	21.48M	21.55M	22M	24.43M	25.06M	25.51M	26.04M	26.47M	6.46M	6.71M	6.2M	5.54M	5.32M	4.31M	3.57M
Goodwill & Intangibles	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a
Total Long-Term Assets	21.88M	21.86M	22.69M	22.78M	23.28M	25.88M	26.53M	26.9M	27.23M	27.24M	7.35M	6.84M	6.33M	7.25M	5.78M	4.38M	3.65M
Total Assets	182.5M	205.34M	218.28M	235.03M	255.07M	179.77M	192.74M	206.02M	223.94M	143.15M	135.02M	146.42M	160.03M	90.7M	98.65M	105.1M	22.1M
Account Payables	2.3M	1.99M	1.46M	1.93M	1.79M	1.49M	553K	1.05M	2.92M	1.72M	1.2M	1.96M	2.4M	1.74M	2.42M	1.31M	611K
Deferred Revenue	n/a	n/a	n/a	n/a	n/a	5.35M	4.57M	n/a	n/a	n/a	3.48M	n/a	3.83M	2.75M	1.95M	n/a	1.77M
Short-Term Debt	n/a	n/a	n/a	2.74M	2.69M	3.04M	3.01M	2.98M	2.96M	2.94M	633K	624K	615K	607K	n/a	n/a	15K
Other Current Liabilities	6.07M	9.6M	3.07M	450K	1.75M	908K	226K	-293K	67K	167K	1.46M	749K	1.49M	1.7M	1.29M	1.28M	262K
Total Current Liabilities	14.91M	14.71M	10.55M	9.66M	12.36M	10.89M	8.89M	8.11M	10.46M	9.96M	5.81M	5M	7.27M	5.83M	5.32M	3.42M	2.66M
Long-Term Debt	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a
Other Long-Term Liabilities	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	67K	127K	n/a	16.65M	215.43M	68K	128.16M
Total Long-Term Liabilities	15.62M	15.96M	16.28M	16.58M	16.87M	17.15M	17.41M	17.65M	17.89M	18.13M	118K	333K	443K	17.16M	216.09M	562K	128.16M
Total Liabilities	30.53M	30.67M	26.83M	26.24M	29.23M	28.05M	26.3M	25.76M	28.35M	28.09M	5.93M	5.34M	7.71M	22.99M	221.4M	3.98M	130.82M
Total Debt	18.77M	19.08M	19.03M	19.32M	19.56M	20.19M	20.41M	20.64M	20.86M	21.07M	684K	830K	975K	1.12M	1.26M	862K	15K
Common Stock	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a
Retained Earnings	-374.23M	-348.39M	-327.35M	-307.01M	-287.31M	-265.18M	-246.66M	-228.37M	-210.9M	-194.34M	-178.44M	-164.97M	-152.14M	-140.5M	-131.66M	-122.81M	-116.89M
Comprehensive Income	263K	607K	-183K	18K	539K	-134K	-223K	-45K	-72K	-147K	-128K	-5K	n/a	n/a	n/a	n/a	n/a
Shareholders Equity	151.97M	174.67M	191.45M	208.78M	225.85M	151.72M	166.44M	180.26M	195.58M	115.05M	129.09M	141.09M	152.31M	67.71M	-122.75M	101.12M	-108.71M
Total Investments	119.4M	148.97M	158.11M	177.36M	185.85M	93.47M	114.28M	135.03M	67.23M	50.41M	68.28M	24.9M	125K	125K	125K	75K	n/a